EXHIBITION APPLE PRIZE DRAW

Visit our exhibitors’ booths throughout the conference and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

Importance of forecasting clinical trial enrollment: an AI enabled approach to increase confidence in feasibility and execution

  • Learn how to pressure-test site footprint through predictive analytics by forecasting enrollment at the country and site level
  • Discover methods to run re-forecasts based on actual study performance for more accurate tracking and adjustments as necessary
  • Gain competitive advantage thru actionable insights to remain agile and avoid costly enrollment delays
  • Learn how to leverage data to identify low-performing sites earlier in the trial process to implement effective risk mitigation tactics

Exploring the UAE’s clinical research landscape: unlocking opportunities and driving innovation

  • The UAE as a prominent hub for research and clinical trials, driven by a focus on healthcare innovation and patient-centric approaches
  • The UAE’s comprehensive regulatory framework that supports and facilitates clinical research
  • Training and upskilling local researchers and clinicians in research methodologies
  • Prioritizing patient-centric approach, engaging patient communities and advocacy groups

PSI’s VISIONAL: enhancing feasibility and enrollment predictions with GenAI

  • Explore how PSI integrates GenAI for protocol similarity searches and enrollment rate predictions, improving accuracy and efficiency in clinical trial planning
  • Learn how VISIONAL™ incorporates three new data sources to enhance site performance analysis and offer insights across 56 countries, supporting better decision-making
  • Discover how VISIONAL™ enables sponsors to quickly generate multi-country feasibility scenarios and budgets in under 30 minutes, streamlining the planning process

Beyond Integration: How AI Creates a Clinical Trial Platform

  • The challenge: Disconnected systems creating blind spots in trial management
  • The opportunity: AI as the connective tissue between documentation and execution
  • The Intelligent Trial Assistant: Natural Language Queries Across ETMF and CTMS
  • AI-Driven Inspection Readiness: Connecting Document Quality to Trial Execution
  • Predictive Trial Health: Using AI to Connect the Dots Between Documents and Operations
  • Smart Document Classification Meets Smart Workflow: End-to-End Trial Automation

PANEL: How to lay the groundwork for a successful rare disease trial through early patient engagement

  • Working closely with patients, caregivers and advocacy groups in clinical trial design
  • The importance of building a close relationship with patients for trials where patients are the expert in their disease
  • Reducing the financial burden of clinical trial participation on patients
  • How to make trial participation easier on patients: where are the main hurdles impacting enrolment?
  • Building long term relationships with patients post clinical trials

Beyond the Middleman: Strategic Outsourcing of IOR/EOR for Global Clinical Trials

  • Demystifying the Importer of Record (IOR) and Exporter of Record (EOR) functions and reframing it as a strategic enabler of cost efficiency, regulatory compliance, and accelerated timelines in global clinical trial logistics
  • What IOR/EOR really means in a clinical context: Role in customs declarations, tax responsibility, and compliance.
  • IOR providers’ responsibilities through HS classification, valuation review, and pre-clearance planning.
  • Best-fit model: When and where to outsource vs. manage in-house.
  • Tax pitfalls in outsourced IOR: Misclassification of goods (e.g., placebo vs. commercial drug), overpaying duties or VAT due to poor documentation control, and ignoring the available tax saving opportunities.
  • Tax planning by design: The importance of implementing a sound IOR strategy to avoid the highlighted tax pitfalls.
  • Walk away with a deeper understanding of IOR/EOR as a strategic lever for improved global clinical execution, guidance on how to incorporate an outsourced IOR for global clinical trials and a “Red Flag Checklist” with critical questions to vet vendors for outsourcing IOR/EOR

CASE STUDY: Improving patient and site experience for rare disease trials

  • Sponsors’ roles in supporting sites in order to increase trial efficiency and decrease overall timelines
  • Where can clinical trial sponsors better support patients with rare diseases both during trials and in the long term?
  • Lessons learned from Moderna’s experience of site and patient engagement during clinical trials